BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 6470196)

  • 21. Extrapyramidal side effects and oral haloperidol: an analysis of explanatory patient and treatment characteristics.
    Moleman P; Schmitz PJ; Ladee GA
    J Clin Psychiatry; 1982 Dec; 43(12):492-6. PubMed ID: 7161250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Akathisia: a distressing complication of neuroleptic treatment.
    Szabadi E
    Compr Ther; 1987 Sep; 13(9):3-6. PubMed ID: 2889560
    [No Abstract]   [Full Text] [Related]  

  • 23. [The therapeutic effectiveness of amantadine (midantan) in parkinsonism syndromes].
    Kiseleva AM; Zlydnikov DM; Mazhinskaia VP; Lebedeva VK; Zakharova NG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):530-4. PubMed ID: 4705408
    [No Abstract]   [Full Text] [Related]  

  • 24. A double-blind randomized clinical trial of rapid tranquilization with I.M. clonazepam and I.M. haloperidol in agitated psychotic patients with manic symptoms.
    Chouinard G; Annable L; Turnier L; Holobow N; Szkrumelak N
    Can J Psychiatry; 1993 Nov; 38 Suppl 4():S114-21. PubMed ID: 8306241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduction in neuroleptic-induced movement disorders after a switch to quetiapine in patients with schizophrenia.
    Cortese L; Caligiuri MP; Williams R; Schieldrop P; Manchanda R; Malla A; Harricharan R
    J Clin Psychopharmacol; 2008 Feb; 28(1):69-73. PubMed ID: 18204344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Akathisia: the syndrome of motor restlessness.
    Friedman JH; Wagner RL
    Am Fam Physician; 1987 Feb; 35(2):145-9. PubMed ID: 2880488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of clonidine in treating neuroleptic-induced akathisia.
    Zubenko GS; Cohen BM; Lipinski JF; Jonas JM
    Psychiatry Res; 1984 Nov; 13(3):253-9. PubMed ID: 6152054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Recent progress in akathisia].
    Horiguchi J; Yamashita H; Kuramoto Y; Mizuno S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1999 Feb; 19(1):1-9. PubMed ID: 10374238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liverpool University Neuroleptic Side-Effect Rating Scale (LUNSERS) as a subjective measure of drug-induced parkinsonism and akathisia.
    Jung HY; Kim JH; Ahn YM; Kim SC; Hwang SS; Kim YS
    Hum Psychopharmacol; 2005 Jan; 20(1):41-5. PubMed ID: 15565639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tardive akathisia.
    Weiner WJ; Luby ED
    J Clin Psychiatry; 1983 Nov; 44(11):417-9. PubMed ID: 6139366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Parkinsonism, depression and akathisia induced by flunarizine, a calcium entry blockade--report of 31 cases].
    Kuzuhara S; Kohara N; Ohkawa Y; Fuse S; Yamanouchi H
    Rinsho Shinkeigaku; 1989 Jun; 29(6):681-6. PubMed ID: 2582681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Amantadine on Agitation in Critically Ill Patients With Traumatic Brain Injury.
    Gramish JA; Kopp BJ; Patanwala AE
    Clin Neuropharmacol; 2017; 40(5):212-216. PubMed ID: 28816834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lorazepam in the treatment of lithium-induced akathisia.
    Yassa R; Groulx B
    J Clin Psychopharmacol; 1989 Feb; 9(1):70-1. PubMed ID: 2496151
    [No Abstract]   [Full Text] [Related]  

  • 34. Amantadine for traumatic brain injury: does it improve cognition and reduce agitation?
    Leone H; Polsonetti BW
    J Clin Pharm Ther; 2005 Apr; 30(2):101-4. PubMed ID: 15811161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Use of the Soviet preparation midantan in the treatment of the Parkinsonian syndrome].
    Balunov OA; Bazhin EF; Morozova ES; Fedotenkova TN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1974; 74(8):1178-81. PubMed ID: 4417237
    [No Abstract]   [Full Text] [Related]  

  • 36. Association of subjective cognitive dysfunction with akathisia in patients receiving stable doses of risperidone or haloperidol.
    Kim JH; Byun HJ
    J Clin Pharm Ther; 2007 Oct; 32(5):461-7. PubMed ID: 17875112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aripiprazole-associated bruxism, akathisia, and parkinsonism in a bipolar patient.
    Caykoylu A; Ekinci O; Ugurlu GK; Albayrak Y
    J Clin Psychopharmacol; 2011 Feb; 31(1):134-5. PubMed ID: 21192162
    [No Abstract]   [Full Text] [Related]  

  • 38. [Propranolol in the treatment of neuroleptic-induced akathisia].
    Wang HL
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1988 Oct; 21(5):303-5, 320. PubMed ID: 2906858
    [No Abstract]   [Full Text] [Related]  

  • 39. Akathisia in adults with mental retardation: development of the Akathisia Ratings of Movement Scale (ARMS).
    Bodfish JW; Newell KM; Sprague RL; Harper VN; Lewis MH
    Am J Ment Retard; 1997 Jan; 101(4):413-23. PubMed ID: 9017087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Revisiting amantadine as a treatment for drug-induced movement disorders.
    Caroff SN; Jain R; Morley JF
    Ann Clin Psychiatry; 2020 Aug; 32(3):198-208. PubMed ID: 32722730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.